Dual Gallium Drug Treatment Against Carbapenem‐Resistant Klebsiella Pneumoniae: Efficacy and Potential Mechanism(s) of Action and Resistance

Author:

Scott Zachary1,Choi Seoung‐ryoung1ORCID,Britigan Bradley E.12ORCID,Narayanasamy Prabagaran1ORCID

Affiliation:

1. Department of Pathology and Microbiology, College of Medicine University of Nebraska Medical Center Omaha Nebraska 68198 USA

2. Department of Internal Medicine, College of Medicine University of Nebraska Medical Center Omaha Nebraska 68198 USA

Abstract

AbstractKlebsiella pneumoniae (KLP) is a Gram‐negative pathogen that can be highly antibiotic‐resistant. Our group has worked with gallium‐based compounds as a means of treating bacterial infections. Here the possible mechanism is investigated for dual therapy comprised of gallium nitrate (Ga(NO3)3) and gallium protoporphyrin (GaPP) on KLP. It is found that in vitro the combination of Ga(NO3)3 and GaPP is synergistic against KLP. The in vivo efficacy is of the dual therapy is additionally tested by treating pulmonary KLP infections in mice. Much greater effectiveness are observed in bacterial clearance and survival of mice receiving the dual therapy than that of singly treated or untreated mice. It is found that in in vitro the dual therapy increased reactive oxygen stress in treated bacteria. Combination therapy impacted KLP catalase, but not superoxide dismutase (SOD) activity. Finally, alterations in KLP genes encoding 6‐phosphogluconate phosphatase or cytochrome C assembly protein are found to be associated with increased resistance to combination gallium therapy, raising the MIC to both Ga(NO3)3 and GaPP by 4‐fold. These cumulative data lend validation to the potential for the use of Ga(NO3)3 and GaPP combination therapy against KLP and suggest that increased oxidative stress is involved in the mechanism of action.

Publisher

Wiley

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3